GLP-1 Peptides Explained: Semaglutide vs. Tirzepatide vs. Retatrutide (Research Guide)
By RUOcodes.com Research Team
Published: · Updated: Sep 12, 2026
Semaglutide vs Tirzepatide vs Retatrutide: how GLP-1 receptor agonists work, how they differ, and what the clinical data shows in 2026.
GLP-1 peptide research comparison: semaglutide, tirzepatide, and retatrutide. For research and educational purposes only. Not medical advice. Three peptides are reshaping how medicine thinks about obesity, metabolic disease, and body composition. Semaglutide opened the door. Tirzepatide blew it off the hinges. Retatrutide is building an entirely different house. If you have been following the biohacking and peptide research space over the past three years, you have watched GLP-1 receptor agonists go from a diabetes management tool to the most talked-about class of compounds in modern medicine. The search volume is extraordinary. The clinical results are extraordinary. And the confusion about what each compound actually is, how they differ mechanistically, what the trials actually showed, and where research peptides fit versus FDA-approved drugs is equally extraordinary. This guide cuts through all of it. How GLP-1 and Related Agonist Peptides Actually Work Start with the biology because without it, the differences between these three compounds make no sense. GLP-1 stands for glucagon-like peptide-1. It is an incretin hormone, meaning it is produced in the gut in response to food intake and signals to the rest of the body that nutrients have arrived. Its natural job is to stimulate insulin secretion from the pancreas in proportion to blood glucose levels, suppress glucagon release to prevent the liver from dumping more glucose into circulation, slow gastric emptying to extend the satiety window after a meal, and act on appetite regulatory centers in the brain — primarily the hypothalamus — to reduce hunger signals. When researchers developed synthetic analogs that mimic and extend GLP-1 activity, they produced compounds that could sustain these effects for hours to days rather than the minutes that natural GLP-1 lasts before enzymes degrade it. The result was a class of drugs with genuinely novel mechanisms for metabolic disease management. GIP stands for glucose-dep…
← Back to Blog